1. Vaccination with chimeric protein induces protection in murine model against ascariasis
- Author
-
Maria Elena Bottazzi, Joseane Camilla de Castro, Bin Zhan, Denise Silva Nogueira, Fabrício Marcus Silva Oliveira, Daniella Castanheira Bartholomeu, Laila Viana de Almeida, Lilian Lacerda Bueno, João Luís Reis-Cunha, Peter J. Hotez, Ricardo Toshio Fujiwara, Luísa Mourão Dias Magalhães, and Mariana Santos Cardoso
- Subjects
Recombinant Fusion Proteins ,030231 tropical medicine ,Monophosphoryl Lipid A ,Epitope ,Mice ,03 medical and health sciences ,0302 clinical medicine ,Antigen ,medicine ,Animals ,030212 general & internal medicine ,Ascaris suum ,B cell ,Ascariasis ,Mice, Inbred BALB C ,General Veterinary ,General Immunology and Microbiology ,biology ,Ascaris ,Vaccination ,Public Health, Environmental and Occupational Health ,biology.organism_classification ,Fusion protein ,Virology ,Disease Models, Animal ,Infectious Diseases ,medicine.anatomical_structure ,Antigens, Helminth ,Molecular Medicine ,Female - Abstract
An estimated 400 million people are infected by parasites of the genus Ascaris and the existing control measures are inefficient. Vaccine development using B cell antigens is a promising strategy for increased protection against this parasite. The present study aimed at developing a chimeric protein capable of conferring protection against infection by Ascaris sp. For this purpose, we performed B-cell epitope predictions on previously described vaccine candidate proteins from Ascaris suum and the corresponding peptides were used to construct a chimeric protein. Female BALB / c mice were immunized subcutaneously in three doses at 10 day intervals with a vaccine formulation comprised of the chimeric protein together with monophosphoryl lipid A (MPLA). Control groups included protein alone, MPLA, or PBS. After challenge infection, animals vaccinated with chimeric protein plus MPLA showed a reduction of 73.54% of larval load in the lung compared to control group animals. Animals immunized with chimeric protein plus MPLA also display higher IgG response and a reduction in lung inflammation. Our study highlights how chimeric proteins containing more than one B cell epitope can enhance immune protection against helminthic infection and offer new approaches to the development of Ascaris vaccines.
- Published
- 2021
- Full Text
- View/download PDF